$NRXP

$2.69 +$0.14 (5.49%) Close

$NRXP Overview Financial Statements SEC Filings Executives News Red Flags Capital Raising Ownership Insider Transactions Congressional Trades

Company Executives

$NRXP Management Team

Mr. Michael Abrams

Chief Financial Officer and Treasurer

Age 55

Compensation -

Sex Male

Mr. Matthew Duffy

Chief Business Officer

Age 63

Compensation $338.0K USD

Sex Male

Dr. Jonathan Javitt

Chairman of the Board

Interim Chief Executive Officer

Chief Scientific Officer

Age 68

Compensation $825.0K USD

Sex Male

Mr. Riccardo Panicucci

Chief Manufacturing and Technology Officer

Age 65

Compensation $240.0K USD

Sex Male

Mr. Joseph Casper

Chief Operating Officer

Age 75

Compensation -

Sex Male

Name / Title	Age	Compensation	Sex
Mr. Michael Abrams Chief Financial Officer and Treasurer	55	-	Male
Mr. Matthew Duffy Chief Business Officer	63	$338.0K USD	Male
Dr. Jonathan Javitt Chairman of the Board Interim Chief Executive Officer Chief Scientific Officer	68	$825.0K USD	Male
Mr. Riccardo Panicucci Chief Manufacturing and Technology Officer	65	$240.0K USD	Male
Mr. Joseph Casper Chief Operating Officer	75	-	Male

Board of Directors

From the proxy statement filed Feb 23, 2026

Directors

serving now

Independent

4 of 4

stated in the proxy; 1 not stated

Average tenure

3.2 years

from year joined

CEO also chairs the board

Yes

Jonathan Javitt, M.D., M.P.H.

Director	Age	On board	Independent	Committees	Other public boards	2024 pay
Jonathan Javitt, M.D., M.P.H. Board chair, CEO	69	Not stated	Not stated	None stated	None stated	Paid as CEO
Patrick J. Flynn	77	2021 5 years	Independent	None stated	None stated	$90,000
Chaim Hurvitz	65	2021 5 years	Independent	None stated	None stated	Not stated
Dennis McBride, Ph.D.	72	2024 2 years	Independent	None stated	None stated	Not stated
Michael Taylor	51	2025 1 year	Independent	Audit Committee	None stated	Not stated

Each director opens the passage of the proxy that names them. "Not stated" means the proxy does not say; it never means "no". Pay is the proxy's Director Compensation table; the CEO is paid as an executive.

2 disclosed in the proxy filed Feb 23, 2026

Daniel C. Javitt

the brother of Jonathan Javitt, the Chairman and Chief Scientist of the Company

$0.3 million and $0.3 million, respectively

years ended December 31, 2024 and 2023

Company licenses patents owned by Glytech, LLC, which Daniel C. Javitt solely owns, and pays for continuing research and development, technology support services and reimbursed expenses.

With Glytech, LLC Open in proxy

Zachary Javitt

the son Jonathan Javitt

$0.1 million and $0.1 million, respectively

years ended December 31, 2024 and 2023

Company pays Zachary Javitt on an hourly basis for website, information technology and marketing support services.

Open in proxy

Comments

Company Executives

$NRXP Management Team

Mr. Michael Abrams

Mr. Matthew Duffy

Dr. Jonathan Javitt

Mr. Riccardo Panicucci

Mr. Joseph Casper

Board of Directors

Related-party transactions